Inventor · disambiguated record
Karen Kozarsky
Also filed as: KOZARSKY KAREN · KOZARSKY KAREN FRAN
10 granted patents·27 pending applications·329 citations·filing 1995–2025
91Inventor score
Top patents by PatentIndex Score
37 records- 0196US7306794B2Methods and compositions for the treatment of defects in lipoprotein metabolismUNIV PENNSYLVANIA·Filed 2005·Granted Dec 11, 2007·39 cites·15 claims
- 0294US5652224AMethods and compositions for gene therapy for the treatment of defects in lipoprotein metabolismUNIV PENNSYLVANIA·Filed 1995·Granted Jul 29, 1997·137 cites·13 claims
- 0393US6887463B2Methods and compositions for the treatment of defects in lipoprotein metabolismUNIV PENNSYLVANIA·Filed 2002·Granted May 3, 2005·38 cites·10 claims
- 0490US9827295B2Methods to treat mucopolysaccharide type I or deficiency in alpha-L-iduronidase using a recombinant adeno-associated virus encoding alpha-L-iduronidaseUNIV MINNESOTA·Filed 2014·Granted Nov 28, 2017·10 cites·26 claims
- 0589US6174527B1Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolismUNIV PENNSYLVANIA·Filed 1996·Granted Jan 16, 2001·66 cites·4 claims
- 0684US12121567B2Methods to treat mucopolysaccharidosis type II or deficiency in iduronate-2-sulfatase using a recombinant adeno-associated virus (AAV) vector encoding iduronate-2-sulfataseUNIV MINNESOTA·Filed 2017·Granted Oct 22, 2024·1 cites·25 claims
- 0782US11779655B2AAV-ABCD1 constructs and use for treatment or prevention of adrenoleukodystrophy (ALD) and/or adrenomyeloneuropathy (AMN)SWANBIO THERAPEUTICS LTD·Filed 2021·Granted Oct 10, 2023·2 cites·15 claims
- 0878US5962322AMethods for modulation of cholesterol transportMASSACHUSETTS INST TECHNOLOGY·Filed 1996·Granted Oct 5, 1999·36 cites·10 claims
- 0978US2023226225A1Adeno-associated virus for therapeutic delivery to central nervous systemUNIV MINNESOTA·Filed 2023·Application pending·0 cites
- 1076US2021346473A1Adeno-associated virus mediated gene transfer to the central nervous systemUNIV MINNESOTA·Filed 2021·Application pending·0 cites
- 1175US2022211875A1Intranasal administration of adeno-associated virus to treat central nervous system disordersUNIV MINNESOTA·Filed 2022·Application pending·0 cites
- 1275US2021085759A1Methods to treat pompe disease using a recombinant adeno-associated virusUNIV MINNESOTA·Filed 2020·Application pending·0 cites
- 1375US2021085760A1Adeno-associated virus mediated gene transfer to the central nervous systemUNIV MINNESOTA·Filed 2020·Application pending·0 cites
- 1472US2024254214A1TREATMENT OF OCULAR DISEASES WITH FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTI-VEGF FabREGENXBIO INC·Filed 2023·Application pending·0 cites
- 1571US2025135041A1Injection of single-stranded or self-complementary adeno-associated virus 9 into the cerebrospinal fluidUNIV EMORY·Filed 2024·Application pending·0 cites
- 1671US2021369871A1Adeno-associated virus for therapeutic delivery to central nervous systemUNIV MINNESOTA·Filed 2021·Application pending·0 cites
- 1769US2019298812A1Adeno-associated virus mediated gene transfer to the central nervous systemUNIV MINNESOTA·Filed 2019·Application pending·0 cites
- 1869US2024108761A1Injection of single-stranded or self-complementary adeno-associated virus 9 into the cerebrospinal fluidUNIV EMORY·Filed 2023·Application pending·0 cites
- 1966US2023057519A1Treatment of Ocular Diseases with Fully-Human Post-Translationally Modified Anti-VEGF FabREGENXBIO INC·Filed 2022·Application pending·0 cites
- 2066US2018271955A1Adeno-associated virus mediated gene transfer to the central nervous systemUNIV MINNESOTA·Filed 2018·Application pending·0 cites
- 2166US2018071373A1Adeno-associated virus for therapeutic delivery to central nervous systemUNIV MINNESOTA·Filed 2017·Application pending·0 cites
- 2266US2018271956A1Methods to treat pompe disease using a recombinant adeno-associated virusUNIV MINNESOTA·Filed 2018·Application pending·0 cites
- 2366US2018271957A1Methods to treat ceroid lipofuscinosis using a recombinant adeno-associated virusUNIV MINNESOTA·Filed 2018·Application pending·0 cites
- 2466US2018264090A1Adeno-associated virus mediated gene transfer to the central nervous systemUNIV MINNESOTA·Filed 2018·Application pending·0 cites
- 2565US2022096659A1Method for improving neurological function in mpsi and mpsii and other neurological disordersUNIV MINNESOTA·Filed 2021·Application pending·0 cites
- 2664US2025320287A1TREATMENT OF OCULAR DISEASES WITH FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTI-VEGF FabREGENXBIO INC·Filed 2025·Application pending·0 cites
- 2763US2018289839A1Intranasal therapeutic delivery of adeno-associated virus to central nervous systemUNIV MINNESOTA·Filed 2016·Application pending·0 cites
- 2862US2024009326A1Aav-abcd1 constructs and use for treatment or prevention of adrenoleukodystrophy (ald) and/or adrenomyeloneuropathy (amn)SWANBIO THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 2956US12070510B2Injection of single-stranded or self-complementary adeno-associated virus 9 into the cerebrospinal fluidUNIV EMORY·Filed 2017·Granted Aug 27, 2024·0 cites·14 claims
- 3056US2019211091A1Treatment of Ocular Diseases with Fully-Human Post-Translationally Modified Anti-VEGF FabREGENXBIO INC·Filed 2019·Application pending·0 cites
- 3155US2020277364A1TREATMENT OF OCULAR DISEASES WITH FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTI-VEGF FabREGENXBIO INC·Filed 2018·Application pending·0 cites
- 3254US2005136005A1Methods for modulation of cholesterol transportUNIV PENNSYLVANIA·Filed 2004·Application pending·0 cites
- 3350US2019127455A1Treatment of Ocular Diseases with Fully- Human Post-Translationally Modified Anti-VEGF FabREGENXBIO INC·Filed 2017·Application pending·0 cites
- 3445US2003167475A1Methods for modulation of cholesterol transportFiled 2002·Application pending·0 cites
- 3544US2019269799A1Method for improving neurological function in mpsi and mpsii and other neurological disordersLAOHARAWEE KANUT·Filed 2017·Application pending·0 cites
- 3642US2011105724A1Novel compoundsCLEGG STEPHANIE JANE·Filed 2008·Application pending·0 cites
- 3730US6962688B1Methods for modulation of cholesterol transportMASSACHUSETTS INST TECHNOLOGY·Filed 1999·Granted Nov 8, 2005·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Karen Kozarsky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →